Treatment of Acute Migraine
Start with NSAIDs (ibuprofen, naproxen, or aspirin) or acetaminophen at adequate doses; if insufficient relief after appropriate dosing, add a triptan to the NSAID (or to acetaminophen if NSAIDs are contraindicated). 1
First-Line Approach: NSAIDs and Acetaminophen
Begin treatment immediately at migraine onset with:
- NSAIDs (aspirin, ibuprofen, naproxen, or diclofenac) as first-line therapy 1, 2
- Acetaminophen as an alternative
- Ensure patients use adequate dosing—many fail initial therapy simply because they're taking subtherapeutic doses 1
Critical pitfall: Before escalating therapy, verify the patient is actually taking the maximum recommended dose of their current medication. Consider increasing the NSAID or acetaminophen dose without exceeding daily limits if pain relief is inadequate 1.
Second-Line: Add a Triptan
If NSAIDs or acetaminophen alone fail at adequate doses, add a triptan to the NSAID (or to acetaminophen when NSAIDs cannot be used). 1 This combination approach is superior to either medication alone 2, 3.
Available triptans include: almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan. Choose based on:
- Route of administration preference (oral, nasal, subcutaneous)
- Cost considerations
- Individual patient response 1
Important: Patients who fail one triptan may respond to another within the same class—don't abandon triptans after a single agent fails 1.
Third-Line Options for Triptan Failures
For patients who don't tolerate or have inadequate response to triptan + NSAID combinations, consider 1:
- CGRP antagonists (gepants): rimegepant, ubrogepant, or zavegepant
- Dihydroergotamine (ergot alkaloid)
- Lasmiditan (5-HT1F agonist)—reserve as last-line option among pharmacologic treatments 1
Key advantage of gepants and lasmiditan: No vasoconstrictive effects, making them suitable for patients with cardiovascular risk factors who cannot use triptans 4, 5.
Special Considerations
Severe Nausea/Vomiting
Use nonoral triptan formulations plus antiemetics (domperidone or metoclopramide) 1, 2
Timing
Treat early—counsel patients to begin treatment as soon as the migraine starts, not after waiting to see if it worsens 1. Early treatment with combination therapy improves efficacy.
Route of Administration
Oral route is generally preferred by patients 1, but consider nasal spray or subcutaneous formulations for rapid onset or when oral absorption is compromised by nausea.
Medications to Absolutely Avoid
Do not use opioids or butalbital for acute migraine treatment 1, 2. These have questionable efficacy, substantial adverse effects, dependency risk, and no role in evidence-based migraine care.
Oral ergot alkaloids should also be avoided—they are poorly effective and potentially toxic 2.
Medication Overuse Headache Warning
Counsel patients about medication overuse headache, defined as headache on ≥15 days/month for ≥3 months due to overuse of acute medications 1. The threshold varies by medication type (≥15 days/month for NSAIDs/acetaminophen; ≥10 days/month for triptans, ergots, opioids, or combination analgesics) 3.
Pregnancy and Lactation
In patients of childbearing potential, pregnant, or breastfeeding individuals, discuss adverse effects of pharmacologic treatments and prioritize acetaminophen as the safest option for mild-to-moderate attacks 1, 3.
When to Consider Preventive Therapy
If episodic migraines occur frequently or acute treatment doesn't provide adequate response, adding preventive medications is warranted 1. This typically applies when patients remain adversely affected on ≥2 days per month despite optimized acute therapy 2.